Physician
Hematology
Dr. Jonathan W. Simons, MD
|
|
Give Review
Jonathan Simons practices Hematology. He studied medicine at Johns Hopkins University School of Medicine. Johns Hopkins University School of Medicine is one of the top medical schools in the US. Johns Hopkins University School of Medicine is ranked 3 in research and 29 in primary care medicine Doctor Jonathan W. Simons, MD has written publications. He has 33 publications published with PubMed. The lastest paper is: 'Multidisciplinary intervention of early, lethal metastatic prostate cancer: Report from the 2015 Coffey-Holden Prostate Cancer Academy Meeting.'
Publications
- Prostate Cancer Immunotherapy: Beyond Immunity to Curability.
- Beyond immune checkpoint blockade: New approaches to targeting host-tumor interactions in prostate cancer: Report from the 2014 Coffey-Holden prostate cancer Academy m...
- The 20th Annual Prostate Cancer Foundation Scientific Retreat report.
- Enzyme 15-lipoxygenase 1 promotes hypoxia-inducible factor 1α turnover and reduces vascular endothelial growth factor expression: implications for angiogenesis.
- Beyond the androgen receptor: New approaches to treating metastatic prostate cancer. Report of the 2013 Prouts Neck Prostate Cancer Meeting.
- The 19th annual prostate cancer foundation scientific retreat.
- The 17th Annual Prostate Cancer Foundation scientific retreat: Meeting report.
- The Prostate Cancer Foundation 16th Annual Scientific Retreat: meeting report.
- SEPT9_v1 up-regulates hypoxia-inducible factor 1 by preventing its RACK1-mediated degradation.
- Phase 1/2 dose-escalation study of a GM-CSF-secreting, allogeneic, cellular immunotherapy for metastatic hormone-refractory prostate cancer.
- Insulin-like growth factor-I-dependent up-regulation of ZEB1 drives epithelial-to-mesenchymal transition in human prostate cancer cells.
- Quantum dots: emerging applications in urologic oncology.
- Granulocyte macrophage colony-stimulating factor--secreting allogeneic cellular immunotherapy for hormone-refractory prostate cancer.
- Nanotechnology applications in cancer.
- Antitumor effect of 2-methoxyestradiol in a rat orthotopic brain tumor model.
- Granulocyte-macrophage colony-stimulating factor-transduced allogeneic cancer cellular immunotherapy: the GVAX vaccine for prostate cancer.
- Phase I/II trial of an allogeneic cellular immunotherapy in hormone-naïve prostate cancer.
- KLF5 promotes cell proliferation and tumorigenesis through gene regulation and the TSU-Pr1 human bladder cancer cell line.
- MSF-A interacts with hypoxia-inducible factor-1alpha and augments hypoxia-inducible factor transcriptional activation to affect tumorigenicity and angiogenesis.
- Human Kruppel-like factor 5 is a target of the E3 ubiquitin ligase WWP1 for proteolysis in epithelial cells.
- Frequent somatic mutations of the transcription factor ATBF1 in human prostate cancer.
- HIF at the crossroads between ischemia and carcinogenesis.
- Exploitation of the HIF axis for cancer therapy.
- Novel therapeutic strategies for androgen-independent prostate cancer: an update.
- Androgens stimulate hypoxia-inducible factor 1 activation via autocrine loop of tyrosine kinase receptor/phosphatidylinositol 3'-kinase/protein kinase B in prostate ca...
- Replicative oncolytic adenoviruses in multimodal cancer regimens.
- Signal transduction and myeloma: new targets, new hope.
- 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF.
- Dibenzoylmethane, a natural dietary compound, induces HIF-1 alpha and increases expression of VEGF.
- Geldanamycin induces degradation of hypoxia-inducible factor 1alpha protein via the proteosome pathway in prostate cancer cells.
- Genomic medicines for oncology: early lessons.
- Multidisciplinary intervention of early, lethal metastatic prostate cancer: Report from the 2015 Coffey-Holden Prostate Cancer Academy Meeting.
Schools
Johns Hopkins University School of Medicine
Johns Hopkins Hospital
Doctors Specialties
- Medical Oncology
- Oncology
- Hematology
Accepted Insurances
- Aetna HMO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
Education
-
Johns Hopkins University -
Massachusetts General Hospital -
Johns Hopkins University School of Medicine
Helpful Reviews
Similar Doctors
|
|
Dr. Carol Y. Nishikubo, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Silvana Martino, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jonathan W. Goldman, MD |
|
|
Dr. Susan Bukata, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kathryn A. Henick, MD |
|
|
Dr. Doris V. Quon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kamalesh K. Sankhala, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Francis P. Cyran, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Arun S. Singh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John M. Timmerman, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Robert A. Klein, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Doris V. Quon, MD |